Association of HLA-DRA, HLA-DQA1, and IL-6 gene variations with susceptibility to multiple sclerosis
- 11 July 2025
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-7
Abstract
Background Multiple sclerosis (MS), which can lead to severe physical or cognitive disability and neurological deficits, is a chronic autoimmune disease affecting the central nervous system (CNS). The etiology and pathogenesis of MS remain unclear; nonetheless, it is asserted that its cause is complex, with genetic predisposition playing a significant role. In this study, our aim was to analyze the relationship between MS and HLA-DRA (rs3135388 and rs3135391), HLA-DQA1 (rs9272346) and IL-6 (rs1800795 and rs1900796) gene polymorphisms, which play an important role in inflammation and immune response. Methods The study included 100 healthy controls and 98 MS patients. Real-time polymerase chain reaction (RT-PCR) was used to analyze variations in rs3135388 and rs3135391 in the HLA-DRA gene, rs9272346 in the HLA-DQA1 gene, and rs1800795 and rs1900796 in the IL-6 gene following DNA isolation from peripheral blood. Statistical techniques were applied to assess the outcomes. Results The results showed a significant difference in IL-6 (rs1800796) G/C (p = 0.024) between the patient and control groups when genotypes and allele distributions were analyzed. HLA-DQA1 (rs9272346) and HLA-DRA (rs3135388 and rs3135391) variations did not substantially differ between the two groups. Similarly, no significant difference was found between the two groups in VitD, B12 and folic acid parameters, and there was no relationship between these parameters and genotypes. Conclusion There is evidence suggesting a significant association between IL-6 (rs1800796) polymorphisms and MS. IL-6 (rs1800796) GC genotype may be associated with disease susceptibility or risk. This should be taken into account in association and intervention studies on MS.Keywords
This publication has 32 references indexed in Scilit:
- Effects of HLA-DRA, HLA-DQA1 and IL-6 Gene Variations to Glatiramer Acetate Resistance in Multiple Sclerosis PatientsBiochemical Genetics, 2025
- Multiple sclerosis: doubling down on MHCTrends in Genetics, 2021
- Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosisActa Neurologica Belgica, 2018
- Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple SclerosisJAMA Neurology, 2016
- The immunogenetics of multiple sclerosis: A comprehensive reviewJournal of Autoimmunity, 2015
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancersPharmacology & Therapeutics, 2014
- Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosisJournal of Neuroimmunology, 2013
- Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-α polymorphisms with risk and clinical course of multiple sclerosis in a Polish populationJournal of Neuroimmunology, 2011
- IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic rolesJournal of Neuroimmunology, 2006
- HLA genotypes in turkish patients with myasthenia gravis: Comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic featuresHuman Immunology, 2004